SenesTech, Inc. (SNES)
NASDAQ: SNES · Real-Time Price · USD
2.220
-0.080 (-3.48%)
Nov 20, 2024, 4:00 PM EST - Market closed
SenesTech Revenue
SenesTech had revenue of $482.00K in the quarter ending September 30, 2024, with 33.89% growth. This brings the company's revenue in the last twelve months to $1.65M, up 38.16% year-over-year. In the year 2023, SenesTech had annual revenue of $1.19M with 17.08% growth.
Revenue (ttm)
$1.65M
Revenue Growth
+38.16%
P/S Ratio
0.66
Revenue / Employee
$66,040
Employees
25
Market Cap
2.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.19M | 174.00K | 17.08% |
Dec 31, 2022 | 1.02M | 419.00K | 69.83% |
Dec 31, 2021 | 600.00K | 318.00K | 112.77% |
Dec 31, 2020 | 282.00K | 139.00K | 97.20% |
Dec 31, 2019 | 143.00K | -154.00K | -51.85% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
IT Tech Packaging | 79.16M |
CN Energy Group. | 66.51M |
Bon Natural Life | 25.56M |
Crown Electrokinetics | 13.46M |
BioNexus Gene Lab | 9.26M |
Golden Minerals Company | 2.81M |
N2OFF | 175.31K |
SNES News
- 4 days ago - SenesTech, Inc. (SNES) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - SenesTech Announces Third Quarter 2024 Financial Results - PRNewsWire
- 8 days ago - SenesTech Launches Evolve™ Rodent Birth Control on Walmart Marketplace - PRNewsWire
- 15 days ago - SenesTech to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - PRNewsWire
- 21 days ago - Evolve™ Registered in Hong Kong; Offering a Revolutionary Non-Lethal Rodent Control Solution - PRNewsWire
- 6 weeks ago - New York City to Pursue Rat Contraception Pilot Program - PRNewsWire
- 2 months ago - SenesTech to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - PRNewsWire
- 3 months ago - SenesTech Announces Closing of Warrant Exercise for $2.3 Million in Gross Proceeds - PRNewsWire